Advertisement

Towards a More User-Friendly Medication Information Delivery to People Living with Multiple Sclerosis: A Case Study with Alemtuzumab

  • Amal Azman
  • Matthieu Poyade
  • James Overell
Chapter
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 1120)

Abstract

Multiple Sclerosis (MS) is an autoimmune disease of the central nervous system which leads to demyelination and neurodegeneration. The T and B cells, the body’s immune cells, start attacking the brain and spinal cord, leading to a variety of symptoms. Alemtuzumab is a recently approved disease-modifying therapy that has been shown to have a very high impact on MS. However, it has many potentially life-threatening side effects which patients are often not aware of. For treatments as effective and risky as Alemtuzumab, patients who are considering it must be well-informed on the process and the potential side effects. Patient education is vital to equip patients with knowledge on their disease and treatment, and has shown to be successful in improving the management of chronic diseases and increasing medication adherence. Unfortunately, the language used is often too complex and at a higher reading level than average patients can comprehend, and available resources such as pamphlets and websites are often disorganized. This research proposes a radically different approach to patient education, using less formal channels such as a mobile application to improve health literacy, using LEMTRADA® (Alemtuzumab) as an example. MS patients were involved in a co-design process to produce a series of user-friendly, intuitive and interactive graphical interfaces which propose plain language, illustrations, animations, audio and Augmented Reality components that aim to enhance patients’ knowledge retention and recall. Finally, nine MS patients along with a senior MS nurse tested the mobile application and answered a usability questionnaire that aimed to compare the delivery of information with typical websites and pamphlets. Results suggested this approach to be highly user-friendly and engaging, improving patients’ understanding of medical information considerably. This research illustrates more engaging channels to communicate with MS patients in order to enhance health literacy.

Keywords

Multiple sclerosis Alemtuzumab Patient education Mobile application Health literacy Co-design Communication illustration 

References

  1. Alsaffar H, Wilson L, Kamdar DP et al (2016) Informed consent: do information pamphlets improve post-operative risk-recall in patients undergoing total thyroidectomy: prospective randomized control study. J Otolaryngol Head Neck Surg 45:14.  https://doi.org/10.1186/s40463-016-0127-5 CrossRefPubMedPubMedCentralGoogle Scholar
  2. Blackwell RW née, Lowton K, Robert G et al (2017) Using experience-based co-design with older patients, their families and staff to improve palliative care experiences in the emergency department: a reflective critique on the process and outcomes. Int J Nurs Stud 68:83–94.  https://doi.org/10.1016/j.ijnurstu.2017.01.002
  3. Brownlee WJ, Hardy TA, Fazekas F, Miller DH (2017) Diagnosis of multiple sclerosis: progress and challenges. Lancet 389:1336–1346.  https://doi.org/10.1016/S0140-6736(16)30959-X CrossRefPubMedGoogle Scholar
  4. Bui D, Nakamura C, Bray BE, Zeng-Treitler Q (2012) Automated illustration of patients instructions. AMIA Annu Symp Proc AMIA Symp 2012:1158–1167PubMedGoogle Scholar
  5. Caon C, Namey M, Meyer C et al (2015) Prevention and management of infusion-associated reactions in the comparison of Alemtuzumab and Rebif® efficacy in multiple sclerosis (CARE-MS) program. Int J MS Care 17:191–198.  https://doi.org/10.7224/1537-2073.2014-030 CrossRefPubMedPubMedCentralGoogle Scholar
  6. Carroll JK, Moorhead A, Bond R et al (2017) Who uses mobile phone health apps and does use matter? A secondary data analytics approach. J Med Internet Res 19:e125.  https://doi.org/10.2196/jmir.5604 CrossRefPubMedPubMedCentralGoogle Scholar
  7. Compston A, Coles A (2008) Multiple sclerosis. Lancet 372:1502–1517. https://doi.org/10.1016/S0140-6736(08)61620-7 CrossRefPubMedGoogle Scholar
  8. Daniali SS, Shahnazi H, Kazemi S, Marzbani E (2016) The effect of educational intervention on knowledge and self-efficacy for pain control in patients with multiple sclerosis. Mater Socio Med 28:283–287.  https://doi.org/10.5455/msm.2016.28.283-287 CrossRefGoogle Scholar
  9. Dolati S, Babaloo Z, Jadidi-Niaragh F et al (2017) Multiple sclerosis: therapeutic applications of advancing drug delivery systems. Biomed Pharmacother 86:343–353.  https://doi.org/10.1016/j.biopha.2016.12.010 CrossRefPubMedGoogle Scholar
  10. DrBarrySinger (2010) The immune attack – multiple sclerosis [video online]. https://www.youtube.com/watch?v=TwqqLhmhonI&t=63s. Access 16 Aug 2018
  11. Eloranta S, Katajisto J, Leino-Kilpi H (2016) Orthopaedic patient education practice. Int J Orthop Trauma Nurs 21:39–48.  https://doi.org/10.1016/j.ijotn.2015.08.002 CrossRefPubMedGoogle Scholar
  12. Hadden KB, Hart JK, Lalla NJ, Prince LY (2017) Systematically addressing hospital patient education. J Hosp Librariansh 17:113–124.  https://doi.org/10.1080/15323269.2017.1291033 CrossRefGoogle Scholar
  13. Hill B, Perri-Moore S, Kuang J et al (2016) Automated pictographic illustration of discharge instructions with Glyph: impact on patient recall and satisfaction. J Am Med Inform Assoc 23:1136–1142.  https://doi.org/10.1093/jamia/ocw019 CrossRefPubMedPubMedCentralGoogle Scholar
  14. Lemtrada (2018) Relapsing MS infusion treatment | LEMTRADA® (alemtuzumab). https://www.lemtrada.com/. Accessed 16 Aug 2018
  15. Lopez-Fernandez O, Kuss DJ, Romo L et al (2017) Self-reported dependence on mobile phones in young adults: a European cross-cultural empirical survey. J Behav Addict 6:168–177.  https://doi.org/10.1556/2006.6.2017.020 CrossRefPubMedPubMedCentralGoogle Scholar
  16. McEwan L, Caon C, Chieffe C et al (2016) Best practices in Alemtuzumab administration. J Infus Nurs 39:93–104.  https://doi.org/10.1097/NAN.0000000000000127 CrossRefPubMedGoogle Scholar
  17. Medscape Campath, Lemtrada (alemtuzumab) dosing, indications, interactions, adverse effects, and more. https://reference.medscape.com/drug/campath-lemtrada-alemtuzumab-342240#4. Accessed 16 Aug 2018
  18. Morgan ER, Laing K, McCarthy J et al (2015) Using tablet-based technology in patient education about systemic therapy options for early-stage breast cancer: a pilot study. Curr Oncol 22:e364–e369.  https://doi.org/10.3747/co.22.2476 CrossRefPubMedPubMedCentralGoogle Scholar
  19. Pecorelli N, Fiore JF, Kaneva P et al (2018) An app for patient education and self-audit within an enhanced recovery program for bowel surgery: a pilot study assessing validity and usability. Surg Endosc 32:2263–2273.  https://doi.org/10.1007/s00464-017-5920-3 CrossRefPubMedGoogle Scholar
  20. Quesenberry AC (2017) Plain language for patient education. J Consum Health Internet 21:209–215.  https://doi.org/10.1080/15398285.2017.1311611 CrossRefGoogle Scholar
  21. Rath L, Vijiaratnam N, Skibina O (2017) Assessing understanding of individual risk and symptoms of progressive multifocal leukoencephalopathy in patients prescribed natalizumab for multiple sclerosis. Intern Med J 47:194–199.  https://doi.org/10.1111/imj.13318 CrossRefPubMedGoogle Scholar
  22. Sanaeinasab H, Saffari M, Hashempour M et al (2017) Effect of a transactional model education program on coping effectiveness in women with multiple sclerosis. Brain Behav 7:e00810.  https://doi.org/10.1002/brb3.810 CrossRefPubMedPubMedCentralGoogle Scholar
  23. Sium A, Giuliani M, Papadakos J (2017) The persistence of the pamphlet: on the continued relevance of the health information pamphlet in the digital age. J Cancer Educ 32:483–486.  https://doi.org/10.1007/s13187-015-0948-3 CrossRefPubMedGoogle Scholar
  24. Statista Number of mobile phone users worldwide 2015–2020 | Statista. https://www.statista.com/statistics/274774/forecast-of-mobile-phone-users-worldwide/. Accessed 11 Aug 2018
  25. Suhling H, Rademacher J, Zinowsky I et al (2014) Conventional vs. tablet computer-based patient education following lung transplantation – a randomized controlled trial. PLoS One 9:e90828.  https://doi.org/10.1371/journal.pone.0090828 CrossRefPubMedPubMedCentralGoogle Scholar
  26. Thompson AJ, Baranzini SE, Geurts J et al (2018) Multiple sclerosis. Lancet 391:1622–1636.  https://doi.org/10.1016/S0140-6736(18)30481-1 CrossRefPubMedGoogle Scholar
  27. Trinh N, Novice K, Lekakh O et al (2014) Use of a brief educational video administered by a portable video device to improve skin cancer knowledge in the outpatient transplant population. Dermatol Surg 40:1233–1239.  https://doi.org/10.1097/DSS.0000000000000148 CrossRefPubMedGoogle Scholar
  28. Zanetti-Yabur A, Rizzo A, Hayde N et al (2017) Exploring the usage of a mobile phone application in transplanted patients to encourage medication compliance and education. Am J Surg 214:743–747.  https://doi.org/10.1016/j.amjsurg.2017.01.026 CrossRefPubMedGoogle Scholar
  29. Zimmer A, Bläuer C, Coslovsky M et al (2015) Optimizing treatment initiation: effects of a patient education program about fingolimod treatment on knowledge, self-efficacy and patient satisfaction. Mult Scler Relat Disord 4:444–450. https://doi.org/10.1016/j.msard.2015.06.010 CrossRefPubMedGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Amal Azman
    • 1
    • 2
  • Matthieu Poyade
    • 1
  • James Overell
    • 3
  1. 1.The School of Simulation and VisualisationThe Glasgow School of ArtGlasgowUK
  2. 2.Anatomy Facility, School of Life Sciences, College of Medical, Veterinary and Life SciencesUniversity of GlasgowGlasgowUK
  3. 3.Department of NeurologyQueen Elizabeth University HospitalGlasgowUK

Personalised recommendations